Or the share price could go lower with the issue of more shares , don't forget the starting of the other part of the company no ucg just coal !!!!!!!!With this company's record lower IMOP
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling